Fenwick Represents Conversa Health in Acquisition by Amwell

Fenwick represented Conversa Health, a leader in automated virtual healthcare, in its definitive agreement to be acquired by Amwell (NYSE: AMWL), a national telehealth leader.

The acquisition expands Amwell’s ability to improve patient care between visits using interactive technologies. More information can be obtained from Amwell’s announcement.

The Fenwick transaction team was led by corporate partners Kris Withrow and Sam Angus and included associates James Li, Victoria Lupu and law clerk Itka Safir; executive compensation and employee benefits partners Marshall Mort and Shawn Lampron, counsel Nicholas Frey and associates Christophe Delrieu and Emily Gulyako; technology transactions partner Stefano Quintini, associates Sophia Chen, Jefferson Lin and Kehl Sink and advisor Sandra Weustink; and privacy and cybersecurity partner Jim Koenig and director Brent Hoard.